A linkage study between bipolar disorder and genes involved in dopaminergic and GABAergic neurotransmission

Psychiatric Genetics

Volumn 6, Issue 2, 1996, Pages 67-73

  De Bruyn, A ^a   Souery, D ^b   Mendelbaum, K ^b   Mendlewicz, J ^b   Van Broeckhoven, C ^a,c  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Bipolar disorder; Candidate genes; Dopaminergic neurotransmission; GABAergic neurotransmission; LOD score method

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; DOPAMINE BETA MONOOXYGENASE; RECEPTOR SUBUNIT;

ADOLESCENT; ADULT; ARTICLE; CHILD; DOPAMINERGIC TRANSMISSION; FAMILY; FEMALE; GABAERGIC TRANSMISSION; GENE LOCUS; GENETIC LINKAGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; MODEL; PRIORITY JOURNAL;

EID: 0029778079     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041444-199622000-00006     Document Type: Article

References (42)

1. Berrettini WH, Nurnberger JI Jr, Hare T, Gershon ES and Post RM (1982) Plasma and CSF GABA in affective illness. British Journal of Psychiatry, 141, 483-487.
2. Berrettini WH, Nurnberger JI Jr, Hare T. Simmons-Alling S, Gershon ES and Post RM (1983) Reduced plasma and CSF GABA in affective illness: effect of lithium carbonate. Biological Psychiatry, 18, 185-194.
3. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, Dilsaver SC, Davis JM, Rush AJ, Small JG, Garza-Trevino ES, Risch SC, Goodnick PJ and Morris DD (1994) Efficacy of divalproex vs. lithium and placebo in the treatment of mania. Journal of the American Medical Association, 271, 918-924.
4. Calabrese JR and Delucchi GA (1990) Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. American Journal of Psychiatry, 147, 431-434.
5. Coon H, Jensen S, Hoff M, Holik J, Plaetke R, Reimherr F, Wender P, Leppert M and Byerley W (1993) A genome-wide search for genes predisposing to manic-depression assuming autosomal dominant inheritance. American Journal of Human Genetics, 52, 1234-1249.
6. Chouinard G, Young SN and Annable L (1982) Antimanic effect of clonazepam. Biological Psychiatry, 18, 451-466.
7. De bruyn A, Mendelbaum K, Sandkuijl LA, Delvenne V, Hirsch D, Staner L, Mendlewicz J and Van Broeckhoven C (1994a) Nonlinkage of bipolar disorder to tyrosine hydroxylase, tyrosinase, and D2 and D4 dopamine receptor genes on chromosome 11. American Journal of Psychiatry, 151, 102-106.
8. De bruyn A, Raeymaekers P, Mendelbaum K, Sandkuijl LA, Raes G, Delvenne V, Hirsch D, Staner L, Mendlewicz, J and Van Broeckhoven C (1994b) Linkage analysis of bipolar illness with X-chromosome DNA markers: a susceptibility gene in Xq27-q28 cannot be excluded. American Journal of Medical Genetics (Neuropsychiatric Genetics), 54, 411-419.
9. De bruyn A, Sovery D, Mendelbaum K, Mendelwicz J and Van Broeckhoven C (1996) Linkage analysis of 2 families with bipolar illness and chromosome 18 markers. Biological Psychiatry, 39, 679-688.
10. Dean M, Lucas-Derse S, Bolos A, O'Brian SJ, Kirkness EF, Fraser CM and Goldman D (1991) Genetic mapping of the β1 GABA receptor gene to human chromosome 4, using a tetranucleotide repeat polymorphism. American Journal of Human Genetics, 49, 621-626.
11. Detera-Wadleigh SD, Hsieh W-T, Berrettini WH, et al. (1994) Genetic linkage mapping for a susceptibility locus to bipolar illness: chromosomes 2, 3, 4, 7, 9, 10p, 11p, 22 and Xpter. American Journal of Medical Genetics, 54, 206-218.
12. Endicott J and Spitzer RL (1978) A diagnostic interview. The schedule for affective disorders and schizophrenia. Archives of General Psychiatry, 35, 837-844.
13. Enrich HM, Dose M and Von Zerssen D (1985) The use of sodium valproate, carbamazepine, and oxcarbazepine in patients with affective disorders. Journal of Affective Disorders, 8, 243-250.
14. Glatt KA, Sinnett D and Lalande M (1992) Dinucleotide repeat polymorphism at the GABAA receptor alpha5 (GABRA5) locus at chromosome 15q11-q13. Human Molecular Genetics, 1, 348.
15. Goodwin FK and Jamison KR (1990) Manic-depressive Illness. Oxford University Press, New York.
16. Gurling H, Smyth C, Kalsi G, Moloney E, Rifkin L, O'Neill J and Murphy P (1995) Linkage findings in bipolar disorder. Nature Genetics, 10, 8-9.
17. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, Bernardi G, Lathrop M and Weissenbach J (1994) The 1993-94 Généthon human genetic linkage map. Nature Genetics, 7, 246-339.
18. Haldane J (1919) The combination of linkage values and the calculation of distances between loci of linked factors. Journal of Genetics, 8, 299-309.
19. Hammon EF, Wilder BJ and Bruni J (1981) Minireview: central actions of valproic acid in man and in experimental models of epilepsy. Life Sciences, 29, 2561-2574.
20. Hauge XY, Grandy DK, Eubanks JH, Evans GA, Civelli O and Litt M (1991) Detection and characterization of additional DNA polymorphisms in the dopamine D2 receptor gene. Genomics, 10, 527-530.
21. A receptor alpha 1-subunit gene (GABRA1) to distal 5q by linkage analysis. Genomics, 14, 745-748.
22. 3 receptor as a useful polymorphism for investigating psychiatric disorders. Psychiatric Genetics, 2, 249-256.
23. Lathrop GM and Lalouel JM (1984) Easy calculations of lod scores and genetic risks on small computers. American Journal of Human Genetics, 36, 460-465.
24. Lathrop GM, Lalouel JM, Julier C and Ott J (1985) Multilocus linkage analysis in humans: detection of linkage and estimation of recombination. American Journal of Human Genetics, 37, 482-498.
25. Mendlewicz J, Leboyer M, De bruyn A, Malafosse A, Sevy S, Hirsch D, Van Broeckhoven C and Mallet J (1991) Absence of linkage between chromosome 11p15 markers and manic-depressive illness in a Belgian pedigree. American Journal of Psychiatry, 148, 1683-1687.
26. Modell JG, Lenox RH and Weiner S (1985) Inpatient clinical trial of lorazepam for the management of manic agitation. Journal of Clinical Psychopharmacology, 5, 109-113.
27. Nahmias J, Burley M-W, Povey S, Porter C, Craig I and Wolfe J (1992) A 19 bp deletion polymorphism adjacent to a dinucleotide repeat polymorphism at the human dopamine β-hydroxylase locus. Human Molecular Genetics, 1, 286.
28. NIH/CEPH Collaborative Mapping Group (1992) A comprehensive genetic linkage map of the human genome. Science, 258, 67-86.
29. Petty F, Kramer GL and Rush AJ (1994) Low plasma GABA is a stable trait marker of mood disorders. Biological Psychiatry, 35, 729 (Abstract).
30. Post RM (1987) Mechanisms of action of carbamazepine and related anticonvulsants in affective illness. In: Psychopharmacology the Third Generation of Progress (Ed HY Meltzer), pp. 567-576. Raven Press, New York.
31. Rice JP, Reich T, Andreasen NC, Endicott J, Van Eerdewegh M, Fishman R, Hirschfeld RMA and Klerman GL (1987a) The familial transmission of bipolar illness. Archives of General Psychiatry, 44, 441-447.
32. Rice JP, Endicott J, Knesevich MA and Rochberg N (1987b) The estimation of diagnostic sensitivity using stability data: an application to major depressive disorder. Journal of Psychiatry Research, 21, 337-345.
33. Seeman P and Lee T (1975) Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science, 188, 1217-1219.
34. Sherrington R, Mankoo B, Attwood J, Kalsi G, Curtis D, Beutow K, Povery S and Gurling H (1993) Cloning of the human dopamine D5 receptor gene and identification of a highly polymorphic microsatellite for the DRD5 locus that shows tight linkage to the chromosome 4p reference marker RAF1P1. Genomics, 18, 423-425.
35. St. Clair D, Blackwood D, Muir W, Carothers A, Walker M, Spowart G, Gosden C and Evans HJ (1990) Association within a family of a balanced autosomal translocation with major mental illness. Lancet, 336, 13-16.
36. Smith M, Wasmuth J, McPherson JD, Wagner C, Grandy D, Civelli O, Potkin S and Litt M (1989) Cosegregation of an 11q22.3-9q22 translocation with affective disorder: proximity of the dopamine D2 receptor gene relative to the translocation breakpoint. American Journal of Human Genetics, 45 (suppl), A220.
37. Spence MA, Amali H, Sadovnik AD, Remic RA, Bailey-Wilson JA, Flodman P and Yee IML (1993) A single major locus is the best explanation for bipolar family data: results of complex segregation analyses. Psychiatric Genetics, 3, 143.
38. Spitzer RL, Endicott J and Robins E (1978) In: Research Diagnostic Criteria for a selected group of functional disorders, 3rd edn. New York State Psychiatric Institute.
39. Straub RE, Lehner T, Loth JE, Alexander JR, Shao W, Luo Y, Sharpe L, Simon R, Gibbon M, Lerer B, Endicott J, Ott J, Gilliam GTC and Baron M (1993) Linkage analysis of bipolar affective disorder: summary of genomic screening results and positive lod scores with markers in region 21q22.3 in one large family. Psychiatric Genetics, 3, 124.
40. Tallman JF, Paul SM, Skolnick P and Gallager DW (1980) Receptors for the age of anxiety: pharmacology of the benzodiazepines. Science, 207, 274-281.
41. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW and Uhl GR (1992) Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics, 14, 1104-1106.
42. Weissenbach J, Gyapay G, Dib C, Vignal A, Morissette J, Milasseau, Vaysseix G and Lathrop M (1992) A second-generation linkage map of the human genome. Nature, 359, 794-801.